These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 32825239)

  • 1. Bile Acid Signaling in Neurodegenerative and Neurological Disorders.
    Grant SM; DeMorrow S
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bile acid receptors FXR and TGR5 signaling in fatty liver diseases and therapy.
    Chiang JYL; Ferrell JM
    Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G554-G573. PubMed ID: 31984784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bile acids are nutrient signaling hormones.
    Zhou H; Hylemon PB
    Steroids; 2014 Aug; 86():62-8. PubMed ID: 24819989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Review of Bile Acid Metabolism and Signaling in Cognitive Dysfunction-Related Diseases.
    Weng ZB; Chen YR; Lv JT; Wang MX; Chen ZY; Zhou W; Shen XC; Zhan LB; Wang F
    Oxid Med Cell Longev; 2022; 2022():4289383. PubMed ID: 35308170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Biosynthesis, Signaling, and Neurological Functions of Bile Acids.
    Kiriyama Y; Nochi H
    Biomolecules; 2019 Jun; 9(6):. PubMed ID: 31208099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bile acid metabolism and signaling.
    Chiang JY
    Compr Physiol; 2013 Jul; 3(3):1191-212. PubMed ID: 23897684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intestinal Farnesoid X Receptor and Takeda G Protein Couple Receptor 5 Signaling in Metabolic Regulation.
    Chiang JY; Pathak P; Liu H; Donepudi A; Ferrell J; Boehme S
    Dig Dis; 2017; 35(3):241-245. PubMed ID: 28249273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Bile Acids in Metabolic Control.
    Molinaro A; Wahlström A; Marschall HU
    Trends Endocrinol Metab; 2018 Jan; 29(1):31-41. PubMed ID: 29195686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear receptors as therapeutic targets in cholestatic liver diseases.
    Zollner G; Trauner M
    Br J Pharmacol; 2009 Jan; 156(1):7-27. PubMed ID: 19133988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacology of bile acid receptors: Evolution of bile acids from simple detergents to complex signaling molecules.
    Copple BL; Li T
    Pharmacol Res; 2016 Feb; 104():9-21. PubMed ID: 26706784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of bile acids on neurological function and disease.
    McMillin M; DeMorrow S
    FASEB J; 2016 Nov; 30(11):3658-3668. PubMed ID: 27468758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The roles of bile acids and sphingosine-1-phosphate signaling in the hepatobiliary diseases.
    Nagahashi M; Yuza K; Hirose Y; Nakajima M; Ramanathan R; Hait NC; Hylemon PB; Zhou H; Takabe K; Wakai T
    J Lipid Res; 2016 Sep; 57(9):1636-43. PubMed ID: 27459945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bile acids and male fertility: From mouse to human?
    Sèdes L; Martinot E; Baptissart M; Baron S; Caira F; Beaudoin C; Volle DH
    Mol Aspects Med; 2017 Aug; 56():101-109. PubMed ID: 28511935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestine farnesoid X receptor agonist and the gut microbiota activate G-protein bile acid receptor-1 signaling to improve metabolism.
    Pathak P; Xie C; Nichols RG; Ferrell JM; Boehme S; Krausz KW; Patterson AD; Gonzalez FJ; Chiang JYL
    Hepatology; 2018 Oct; 68(4):1574-1588. PubMed ID: 29486523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New therapies target the toxic consequences of cholestatic liver disease.
    Jansen PLM
    Expert Rev Gastroenterol Hepatol; 2018 Mar; 12(3):277-285. PubMed ID: 29310470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Farnesoid X receptor induces Takeda G-protein receptor 5 cross-talk to regulate bile acid synthesis and hepatic metabolism.
    Pathak P; Liu H; Boehme S; Xie C; Krausz KW; Gonzalez F; Chiang JYL
    J Biol Chem; 2017 Jun; 292(26):11055-11069. PubMed ID: 28478385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic targeting of bile acids.
    Camilleri M; Gores GJ
    Am J Physiol Gastrointest Liver Physiol; 2015 Aug; 309(4):G209-15. PubMed ID: 26138466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New insights in the multiple roles of bile acids and their signaling pathways in metabolic control.
    de Boer JF; Bloks VW; Verkade E; Heiner-Fokkema MR; Kuipers F
    Curr Opin Lipidol; 2018 Jun; 29(3):194-202. PubMed ID: 29553998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bile Acids Activated Receptors Regulate Innate Immunity.
    Fiorucci S; Biagioli M; Zampella A; Distrutti E
    Front Immunol; 2018; 9():1853. PubMed ID: 30150987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bile acids and their receptors.
    Martinot E; Sèdes L; Baptissart M; Lobaccaro JM; Caira F; Beaudoin C; Volle DH
    Mol Aspects Med; 2017 Aug; 56():2-9. PubMed ID: 28153453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.